ID   ONHL-1
AC   CVCL_QY36
DR   Wikidata; Q54936416
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2249898;
CC   Population: Japanese.
CC   Doubling time: 25 hours (PubMed=2249898).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//
RX   PubMed=2249898; DOI=10.1002/ijc.2910460626;
RA   Matsumura I., Tamaki T., Katagiri S., Taniwaki M., Tominaga N.,
RA   Oritani K., Iida M., Yagura H., Yonezawa T., Tarui S.;
RT   "Establishment and characterization of a new human B-cell line
RT   (ONHL-1) from non-Hodgkin's lymphoma: constant expression of bcl-2
RT   gene during mitogen-induced growth inhibition.";
RL   Int. J. Cancer 46:1107-1111(1990).
//